Leukocyte-Poor Platelet-Rich Plasma-Derived Growth Factors Enhance Human Fibroblast Proliferation In Vitro

다국어 초록 (Multilingual Abstract)

Background: Leukocyte-poor platelet-rich plasma (LP-PRP) from peripheral blood is currently used as a concentrated source of growth factors to stimulate repair at sites of soft tissue injury. Fibroblasts are primary mediators of wound healing. Thus, we aimed to assess the positive effect of LP-PRP on human fibroblast proliferation in vitro .
Methods: LP-PRP was prepared from 49 donors. The fibroblasts were seeded, and at 24 hours after seeding, 1 × 107/10 μL LP-PRP was added once to each well. The cells were harvested 10 times during study period at our planned points, and we examined cell proliferation using the water-soluble tetrazolium salt-1 assay. We collected the supernatants and measured the amount of growth factors such as platelet-derived growth factor (PDGF)-AB/BB, insulin-like growth factor-1 (IGF-1), transforming growth factor-β1 (TGF-β1), and vascular endothelial growth factor (VEGF), which are known to be involved in wound healing processes, by multiplex assay.
Results: Human fibroblasts treated with LP-PRP showed a significant increase in proliferation when compared to untreated controls (p < 0.001 at days 4, 6, and 8). Multiplex cytokine assays revealed various secretion patterns. PDGF-AB/BB appeared at early time points and peaked before fibroblast proliferation. IGF-1 and TGF-β1 secretion gradually increased and peaked on days 4 and 6 post-treatment. The early VEGF concentration was lower than the concentration of other growth factors but increased along with cell proliferation.
Conclusions: Platelets in LP-PRP release growth factors such as PDGF, IGF-1, TGF-β1 and VEGF, and these growth factors have a promoting effect for human fibroblast proliferation, one of the important mediators of wound healing. These results suggest that growth factors derived from LP-PRP enhance the proliferation of human fibroblast.

참고문헌 (Reference)

1 Dvorak HF, "Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation" 107 (107): 233-235, 1995

2 Lind M, "Transforming growth factor-beta stimulates bone ongrowth: hydroxyapatite-coated implants studied in dogs" 67 (67): 611-616, 1996

3 Mazzocca AD, "The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells" 40 (40): 1742-1749, 2012

4 Graziani F, "The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts" 17 (17): 212-219, 2006

5 Lynch SE, "Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors" 84 (84): 7696-7700, 1987

6 Werner S, "Regulation of wound healing by growth factors and cytokines" 83 (83): 835-870, 2003

7 Frechette JP, "Platelet-rich plasmas: growth factor content and roles in wound healing" 84 (84): 434-439, 2005

8 DeLong JM, "Platelet-rich plasma: the PAW classification system" 28 (28): 998-1009, 2012

9 Osterman C, "Platelet-rich plasma increases anti-inflammatory markers in a human coculture model for osteoarthritis" 43 (43): 1474-1484, 2015

10 Mazzocca AD, "Platelet-rich plasma differs according to preparation method and human variability" 94 (94): 308-316, 2012

11 Kaigler D, "Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration" 11 (11): 375-385, 2011

12 Kushida S, "Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems" 17 (17): 186-192, 2014

13 Tokunaga A, "PDGF receptor beta is a potent regulator of mesenchymal stromal cell function" 23 (23): 1519-1528, 2008

14 McCarrel TM, "Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy" 94 (94): e143-, 2012

15 Mazzucco L, "Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure" 97 (97): 110-118, 2009

16 Behera P, "Leukocyte-poor platelet-rich plasma versus bupivacaine for recalcitrant lateral epicondylar tendinopathy" 23 (23): 6-10, 2015

17 Sanchez M, "Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study" 26 (26): 910-913, 2008

18 Smith PA, "Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA-sanctioned, randomized, doubleblind, placebo-controlled clinical trial" 44 (44): 884-891, 2016

19 Bennett NT, "Growth factors and wound healing: biochemical properties of growth factors and their receptors" 165 (165): 728-737, 1993

20 Sundman EA, "Growth factor and cata- bolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma" 39 (39): 2135-2140, 2011

21 Le Pillouer-Prost A, "Fibroblasts: what's new in cellular biology?" 5 (5): 232-238, 2003

22 Olesen JL, "Expression of insulin-like growth factor I, insulin-like growth factor binding proteins, and collagen mRNA in mechanically loaded plantaris tendon" 101 (101): 183-188, 2006

23 Yun JH, "Effects of bone marrowderived mesenchymal stem cells and platelet-rich plasma on bone regeneration for osseointegration of dental implants: preliminary study in canine three-wall intrabony defects" 102 (102): 1021-1030, 2014

24 Duif C, "Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled doubleblind trial" 135 (135): 971-977, 2015

25 Everts PA, "Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation" 16 (16): 363-368, 2006

26 Wasterlain AS, "Contents and formulations of platelet-rich plasma" 22 (22): 33-42, 2012

27 Radice F, "Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors" 26 (26): 50-57, 2010

28 Magalon J, "Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model" 30 (30): 629-638, 2014

29 Boyce ST, "Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture" 81 (81): 33s-40s, 1983

30 Byrne AM, "Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF)" 9 (9): 777-794, 2005